Company Overview

Trellus Health plc is a digital health company focused on improving outcomes for people living with chronic gastrointestinal (GI) conditions, with an initial and primary emphasis on inflammatory bowel disease (IBD). The company operates at the intersection of healthcare technology, behavioral science, and specialty care, providing evidence-based digital therapeutics and integrated care solutions designed to complement traditional medical treatment. Trellus Health primarily serves healthcare providers, health systems, employers, and life sciences partners seeking scalable solutions to manage chronic GI conditions and associated healthcare costs.

The company’s core offering is a proprietary digital care platform that combines cognitive behavioral therapy (CBT), self-management education, and remote care coordination. Trellus Health positions itself uniquely by targeting the psychosocial drivers of chronic disease outcomes, which are often under-addressed in conventional care models. The company was founded in 2016 by Dr. Laurie Keefer, a behavioral health expert in gastroenterology, and evolved from an academic research-based model into a commercial digital health enterprise. Trellus Health became a publicly traded company in 2022 following a business combination with a special purpose acquisition company, resulting in its listing on U.S. public markets.

Business Operations

Trellus Health operates primarily through a single integrated business model centered on its digital platform, marketed as Trellus Elevate™, which delivers structured, evidence-based interventions for chronic GI conditions. Revenue is generated through enterprise contracts with health plans, self-insured employers, provider organizations, and strategic partners, typically on a per-member-per-month or program-based pricing structure. The platform supports patient onboarding, digital coaching, behavioral interventions, and data analytics intended to improve adherence, quality of life, and clinical outcomes.

Operationally, the company conducts research, product development, clinical validation, and commercialization activities through its wholly owned subsidiary, Trellus Health Inc., which serves as the primary operating entity. While the platform is technology-enabled, its services are delivered in conjunction with trained health coaches and clinicians, integrating human support with digital tools. As of publicly available disclosures, Trellus Health does not report multiple operating segments, instead managing its business as a single reporting unit focused on digital chronic care management.

Strategic Position & Investments

Trellus Health’s strategic direction centers on expanding adoption of its digital care model within the U.S. healthcare system, particularly among payers and large employer groups seeking value-based care solutions. Growth initiatives include broadening clinical indications beyond IBD to other chronic GI and immune-mediated conditions, enhancing data analytics capabilities, and integrating outcomes data to support reimbursement and long-term contracting.

The company has emphasized investment in clinical validation, peer-reviewed research, and platform enhancement rather than large-scale acquisitions. Strategic collaborations with healthcare providers, academic institutions, and industry partners support both product development and market penetration. Public disclosures indicate that Trellus Health remains focused on organic growth and commercialization of its existing platform rather than maintaining a diversified portfolio of subsidiaries or unrelated investments. Data inconclusive based on available public sources regarding material equity investments or joint ventures beyond routine commercial partnerships.

Geographic Footprint

Trellus Health plc is incorporated in the United Kingdom, with operational headquarters and primary business activities based in North America, particularly the United States, which represents its largest market. The company’s solutions are designed for scalability and remote delivery, allowing it to support patients and enterprise customers across multiple U.S. states without the need for extensive physical infrastructure.

Internationally, the company maintains a corporate presence in Europe through its U.K. incorporation and selectively engages with partners and stakeholders outside the United States. However, publicly available information indicates that the majority of revenue-generating activities and commercial focus remain concentrated in the U.S. healthcare market, with limited disclosed revenue contribution from other regions.

Leadership & Governance

Trellus Health was founded by Dr. Laurie Keefer, whose clinical and academic work in behavioral gastroenterology underpins the company’s care model. The leadership team emphasizes an outcomes-driven, evidence-based philosophy, integrating behavioral science with digital health to address unmet needs in chronic disease management. Governance is overseen by a board of directors with experience across healthcare, life sciences, and public company management.

Key executives include:

• Dr. Laurie Keefer – Chief Executive Officer
• Jessica Tanner – Chief Operating Officer
• Chris Sehar – Chief Financial Officer
• Michael Bell – Chief Technology Officer

The leadership team’s stated strategic vision focuses on advancing whole-person care, generating clinically validated outcomes, and aligning with value-based healthcare incentives while maintaining regulatory and public-company governance standards.